AMCAP™ IVT Intermediate Kit

Description

AMCAP™ Intermediate IVT Kit represents the all-in-one solution for generating high quality, Cap-1 mRNA.

Key Features and Benefits:
• Innovative One-Pot Synthesis: The kit utilizes the patent-pending AMCAP™ process, combining In Vitro Transcription (IVT) and Capping in a single, streamlined reaction (ONE POT synthesis).
• Superior Capping Efficiency: Achieve significantly higher levels of the critical Cap-1 structure on the 5′ end of your mRNA compared to standard two-step enzymatic capping. The AMCAP™ technology is shown to deliver high mRNA capping efficiency.
• High Yield: The AMCAP™ reaction delivers high mRNA production yield compared to both standard two-step enzymatic capping and co-transcriptional processes.
• Enhanced Protein Expression: mRNA synthesized with AMCAP™ shows a higher level of protein expression in transfected cells compared to standard two-step enzymatic capping.
• Reduced Processing Steps and Time: By eliminating separate capping steps, the AMCAP™ technology reduces overall processing time, costs, and the number of required steps, all while maintaining high mRNA quality.

AMCAP™ Intermediate mRNA IVT Kit is ready-to-use and is available with or without pseurouridine modification.

Kit includes:
-1 vial of AMCAP™ IVT Intermediate;
-1 vial of pAMC_EGFP linearized template.

Data & IP Statements

Products are not for resale without express written permission from Anemocyte s.r.l.

Any and all Intellectual Property Rights (means any and all rights in and to any and all intellectual property – whether registerable or patentable or not – including, but not limited to, names, trademarks, domain, trade names, designs, works of authorship, patents for inventions and utility models, processes, trade secrets, software, platforms, technology, know-how, sequencies and any other intellectual property) belong to Anemocyte s.r.l., which is their full, exclusive and unconditional owner, or are lawfully held or otherwise within legitimate possession or control of Anemocyte s.r.l.
No license under any patent or other Intellectual Property Rights of Anemocyte s.r.l. or its licensors is granted or implied by the purchase unless otherwise provided in writing.
Without prejudice to the foregoing, these products are manufactured using a Anemocyte s.r.l technology which is currently patent pending. Anemocyte s.r.l does not warrant that the use or sale of the products will not infringe the claims of any patents or patents pending, covering the use of the product alone or in combination with other products or in the operation of any process.

For further information contact sales@anemocyte.com